Clinical Trial Update: PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating PD-1 blockade with de-intensified chemoradiotherapy that spares concurrent cisplatin in Nasopharyngeal Carcinoma; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• PD-1 blockade (unspecified)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING